Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
1 clinical trials · Condition
◉ Watch Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer (NCT01814865) | British Columbia Cancer Agency | 2013-05-01 |
Track Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.